Peripheral blood stem cell transplantation in acute myeloid leukemia: The experience of the bordeaux group

STEM CELLS

Volumn 13, Issue 3 S, 1995, Pages 19-22

  Reiffers, Josy ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Acute myeloid leukemia; Stem cells; Transplantation

Indexed keywords

CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL ISOLATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONFERENCE PAPER; HEMATOPOIETIC STEM CELL; HUMAN; TREATMENT OUTCOME;

BLOOD SPECIMEN COLLECTION; CELL DIVISION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; RECURRENCE;

EID: 0028825892     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.5530130704     Document Type: Article

References (15)

1. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia
2. Autologous blood stem cell grafting in hematological malignancies. Present status and future directions
3. + hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide‐treated patients: enhancement by intravenous recombinant human granulocyte‐macrophage colony stimulating factor
4. Granulocyte‐macrophage colony stimulating factor expands the circulating hemopoietic progenitor cell compartment in man
5. Stem cell apheresis in patients with acute non‐lymphocytic leukemia
6. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia first complete remission
7. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients
8. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment
9. Granulocyte macrophage progenitor numbers in peripheral blood stem cell autotransplantation
10. Hemopoietic reconstitution after autologous blood stem cell transplantation
11. Is there a place for blood stem cell transplantation for the younger adult patient with acute myelogenous leukemia
12. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease‐free survival
13. Post‐remission therapy for acute myeloid leukemia with blood‐derived stem cell transplantation. Results of a collaborative phase II trial
14. Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution
15. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: an European survey: the role of marrow purging